US Patent 9828408 HCV polymerase inhibitors
Patent 9828408 was granted and assigned to Medivir on November, 2017 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9828408 HCV polymerase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
